Effects of a bradykinin B2 receptor antagonist on ischemia-reperfusion injury in a canine lung transplantation model

Journal of Heart and Lung Transplantation

Volumn 23, Issue 5, 2004, Pages 606-613

  Hashimoto, Naoki ^a   Takeyoshi, Izumi ^a   Tsutsumi, Hirofumi ^a   Sunose, Yutaka ^a   Tokumine, Masahiko ^a   Totsuka, Osamu ^a   Ohwada, Susumu ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ B2 RECEPTOR ANTAGONIST; EURO COLLINS SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BRONCHUS; CELL COUNT; CONTROLLED STUDY; DOG; DONOR; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL MODEL; GRAFT SURVIVAL; HEART OUTPUT; HISTOPATHOLOGY; ISCHEMIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PULMONARY ARTERY; RANDOMIZATION; RECIPIENT; REPERFUSION INJURY;

ANIMALS; CARBON DIOXIDE; CARDIAC OUTPUT; DOGS; HYPERTONIC SOLUTIONS; LUNG; LUNG TRANSPLANTATION; NEUTROPHILS; ORGAN SIZE; PARTIAL PRESSURE; QUINOLINES; RANDOM ALLOCATION; RECEPTOR, BRADYKININ B2; REPERFUSION INJURY;

EID: 2342574690     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00297-3     Document Type: Article

References (30)

1. McFadden P.M., Emory W.B. Lung transplantation. Surg Clin North Am. 78:1998;749-762
2. Kirk A.J., Colquhoun I.W., Dark J.H. Lung preservation A review of current practice and future directions. Ann Thorac Surg. 56:1993;990-1000
3. Keck BM, Bennett LE, Fiol BS, Daily OP, Novick RJ, Hosenpud JD. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl 1998;39-52
4. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., Novick R.J. The registry of the International Society for Heart and Lung Transplantation Sixteenth official report - 1999. J Heart Lung Transplant. 18:1999;611-626
5. Morganroth M.L., Till G.O., Schoeneich S., Ward P.A. Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement. Lab Invest. 58:1988;316-323
6. Cooper JD, Pohl MS, Patterson GA. An update on the current status of lung transplantation: report of the St. Louis International Lung Transplant Registry. Clin Transpl 1993;95-100
7. Theodore J., Lewiston N. Lung transplantation comes of age. N Engl J Med. 332:1990;772-774
8. Naka Y., Roy D.K., Smerling A.J., et al. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg. 110:1995;1434-1441
9. Hamberg M., Svensson J., Samuelsson B. Novel transformation of arachidonic acid in human platelets. Proc Natl Acad Sci USA. 71:1974;3400-3404
10. 2. Proc Natl Acad Sci USA. 84:1987;6374-6379
11. 2 in bovine pulmonary arteryendothelial cells. Agents Actions. 40:1993;110-118
12. 2 and C. J Biol Chem. 263:1988;14640-14647
13. 2 receptor antagonist, FR173657. Br J Pharmacol. 120:1997;617-624
14. 2 receptor antagonist, FR173657, on pulmonary ischemia-reperfusion injury in dogs. J Heart Lung Transplant. 21:2002;1022-1029
15. Bathon J.M., Proud D. Bradykinin antagonists. Annu Rev Pharmacol Toxicol. 31:1991;129-162
16. 1 receptors: a review. Immunopharmacology. 30:1995;1-26
17. Hoffmann T.F., Waldner H., Messmer K. The bradykinin antagonist CP-0597 can limit the progression of postischemic pancreatitis. Immunopharmacology. 33:1996;243-246
18. Turnage R.H., Kadesky K.M., Bartula L., Myers S. Pulmonary thromboxane release following intestinal reperfusion. J Surg Res. 58:1995;552-557
19. Bacha E.A., Herve P., Murakami S., et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. J Thorac Cardiovasc Surg. 112:1996;590-598
20. Lehr H.A., Guhlmann A., Nolte D., Keppler D., Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest. 87:1991;2036-2041
21. Naka Y., Roy D.K., Liao H., et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Circ Res. 79:1996;773-783
22. Bhabra M.S., Hopkinson D.N., Shaw T.E., Hooper T.L. Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation. Ann Thorac Surg. 62:1996;1494-1499
23. Simon L.S. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 106:(suppl):1999;37S-42S
24. Kaplan E., Diehl J.T., Peterson M.B., et al. Extended ex vivo preservation of the heart and lungs. Effects of acellular oxygen-carrying perfusates and indomethacin on the autoperfused working heart-lung preparation. J Thorac Cardiovasc Surg. 100:1990;687-698
25. 2 synthetase inhibitor against ischemic liver injury. Surg Today. 24:1994;435-440
26. Sunose Y., Takeyoshi I., Ohwada S., et al. The effect of FK409 - a nitric oxide donor - on canine lung transplantation. J Heart Lung Transplant. 19:2000;298-309
27. 2 moderates permeability after limb ischemia. Ann Surg. 202:1985;642-646
28. Post S., Goerig M., Otto G., et al. Rapid increase in the activity of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after experimental liver transplantation. Transplantation. 51:1991;1058-1064
29. Wiemer G., Schölkens B.A., Linz W. Endothelial protection by converting enzyme inhibitors. Cardiovasc Res. 28:1994;166-172
30. Linz W., Wiemer G., Schölkens B.A. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size. Am J Cardiol. 80:1997;118-123